07:40 AM EDT, 05/29/2024 (MT Newswires) -- Affimed ( AFMD ) said Wednesday that the US Food and Drug Administration has granted Fast Track designation for its potential treatment of patients with advanced and/or metastatic non-small cell lung cancer without any activating epidermal growth factor receptor following targeted therapy and platinum-based chemotherapy. The treatment combines Affimed's ( AFMD ) innate...

07:41 AM EDT, 05/29/2024 (MT Newswires) -- Dick's Sporting Goods (DKS) reported fiscal Q1 non-GAAP earnings Wednesday of $3.30 per diluted share, down from $3.40 a year earlier. Analysts polled by Capital IQ expected $2.97. Net sales for the quarter ended May 4 were $3.02 billion, up from $2.84 billion a year earlier. Analysts surveyed by Capital IQ expected $2.94...

07:37 AM EDT, 05/29/2024 (MT Newswires) -- Definity Financial Corporation ( DFYFF ) , which lost 2.4% yesterday, on Wednesday said it has received Toronto Stock Exchange approval to renew its normal course issuer bid (NCIB). Beginning May 31, the company can purchase up to 3.5 million of its common shares for one year. Definity may also purchase its common...

07:40 AM EDT, 05/29/2024 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) said Wednesday that the European Commission has approved its cancer drug Opdivo, or nivolumab, combined with cisplatin and gemcitabine as first-line treatment for unresectable or metastatic urothelial carcinoma in adults. The company said the approval was based on phase 3 trial results showing statistically significant and clinically meaningful...